LON:PRTC PureTech Health (PRTC) Share Price, News & Analysis GBX 140.60 -0.40 (-0.28%) As of 06/16/2025 11:59 AM Eastern Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsHeadlinesBuy This Stock About PureTech Health Stock (LON:PRTC) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get PureTech Health alerts:Sign Up Key Stats Today's Range 137.80▼ 141.8050-Day Range 103▼ 144.4052-Week Range 100.40▼ 225Volume138,625 shsAverage Volume801,645 shsMarket Capitalization£422.34 millionP/E RatioN/ADividend YieldN/APrice TargetGBX 455Consensus RatingBuy Company OverviewPureTech Health plc, a clinical-stage biopharma company, focuses on developing medicines for diseases caused by dysfunctions in the nervous, gastrointestinal, and immune systems. The company is developing a microbiome immune system drug-discovery platform and drug candidates for immune-mediated diseases; and products to induce weight loss and enhance glycaemic control through an orally administered capsule. It is also developing technology and products for screening, diagnosis, and treatment of neurological disorders, such as ADHD, autism, and depression through computer software; noninvasive neurostimulation treatment for psychiatric disorders; and combination therapy for schizophrenia. In addition, the company is developing drug delivery platform for oral administration of proteins, peptides, and other difficult-to-deliver payloads; products to generate new human hair follicles and hair; drug delivery platform for drugs that treat inflammation and associated disorders; platform to address immunosenescence; novel targeted immunotherapies for cancer; monoclonal antibodies for immuno-suppressive gamma delta T cells in pancreatic and colorectal cancers, and other solid tumors; novel approaches to enhance delivery and distribution of therapeutics; and digital health technologies, as well as engages in enhancing health through food through the creation of nutrition technology. Further, it is developing a platform and products that take in physiological data from sensors and correlates that data with musical data components; voice-based tools for passive assessment and tracking of patient health; commensal organism-based products for enhancing human health; and technology platform to identify experts in healthcare and other research-based disciplines, as well as engages in identifying healthcare expert networks and reviewing their conversations and content on social media. The company was incorporated in 2015 and is based in Boston, Massachusetts.Read More… PureTech Health Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks28th Percentile Overall ScorePRTC MarketRank™: PureTech Health scored higher than 28% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.5 / 5Analyst RatingBuy Consensus RatingPureTech Health has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.Amount of Analyst CoveragePureTech Health has received no research coverage in the past 90 days.Read more about PureTech Health's stock forecast and price target. Earnings and Valuation0.0 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of PureTech Health is -5.77, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of PureTech Health is -5.77, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioPureTech Health has a P/B Ratio of 1.24. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Short InterestN/AShort Interest LevelN/A Short InterestThere is no current short interest data available for PRTC. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldPureTech Health does not currently pay a dividend.Dividend GrowthPureTech Health does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Short InterestThere is no current short interest data available for PRTC. News and Social Media0.0 / 5News SentimentN/A News Coverage This WeekMarketBeat has tracked 1 news article for PureTech Health this week, compared to 1 article on an average week. Company Ownership2.5 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, PureTech Health insiders have not sold or bought any company stock.Percentage Held by Insiders15.93% of the stock of PureTech Health is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions79.86% of the stock of PureTech Health is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about PureTech Health's insider trading history. Receive PRTC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for PureTech Health and its competitors with MarketBeat's FREE daily newsletter. Email Address PRTC Stock News HeadlinesShareholders In PureTech Health (LON:PRTC) Should Look Beyond Earnings For The Full StoryMay 7, 2025 | uk.finance.yahoo.comExamining Cashflow Against PureTech Health's EarningsMay 7, 2025 | finance.yahoo.comSomething Big Is Coming...Man who predicted Lehman Crash Warns "Get OUT of Cash" He predicted the 2008 crisis and recommended shorting Lehman for an 82% return in just five months... And he predicted the fall of the Nasdaq on the exact day it started crashing in 2021. Today, he's explaining why the dollar has lost more value in 2025 than in ANY year since Lehman collapsed.June 17, 2025 | Stansberry Research (Ad)PureTech Health plc (NASDAQ:PRTC) Q4 2024 Earnings Call TranscriptMay 2, 2025 | msn.comPureTech Health plc – American Depositary Shares trading halted, volatility trading pauseApril 8, 2025 | markets.businessinsider.comPureTech Health plc – American Depositary Shares trading resumesApril 8, 2025 | markets.businessinsider.comPureTech Health and Nordic Capital in Talks for Possible Cash OfferApril 7, 2025 | marketwatch.comPureTech Rejects Nordic Capital Takeover ProposalApril 7, 2025 | marketwatch.comSee More Headlines PRTC Stock Analysis - Frequently Asked Questions How have PRTC shares performed this year? PureTech Health's stock was trading at GBX 150.20 on January 1st, 2025. Since then, PRTC stock has decreased by 6.4% and is now trading at GBX 140.60. View the best growth stocks for 2025 here. How do I buy shares of PureTech Health? Shares of PRTC stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock. What other stocks do shareholders of PureTech Health own? Based on aggregate information from My MarketBeat watchlists, some other companies that PureTech Health investors own include IQE (IQE), Royal Dutch Shell (RDSB), BP (BP), GSK (GSK), Hummingbird Resources (HUM), Plug Power (PLUG) and AstraZeneca (AZN). Industry, Sector and Symbol Stock ExchangeLON SectorMedical Industry Biotechnology Sub-IndustryN/A Current SymbolLON:PRTC CIKN/A Webpuretechhealth.com Phone+1-617-4822333FaxN/AEmployees300Year FoundedN/APrice Target and Rating Average Stock Price TargetGBX 455 High Stock Price TargetGBX 455 Low Stock Price TargetGBX 455 Potential Upside/Downside+223.6%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage1 Analysts Profitability EPS (Most Recent Fiscal Year)GBX (24.38) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-£91.86 million Net Margins-17,620.94% Pretax MarginN/A Return on Equity-21.15% Return on Assets-13.39% Debt Debt-to-Equity Ratio45.82 Current Ratio3.68 Quick Ratio2.51 Sales & Book Value Annual Sales£521.32 thousand Price / Sales810.13 Cash FlowGBX 65.65 per share Price / Cash Flow2.14 Book ValueGBX 113.55 per share Price / Book1.24Miscellaneous Outstanding Shares300,381,095Free FloatN/AMarket Cap£422.34 million OptionableNot Optionable Beta1.02 20 Stocks to Sell NowToday, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.Get This Free Report This page (LON:PRTC) was last updated on 6/17/2025 by MarketBeat.com Staff From Our PartnersAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredWhen This Happens, You Don’t Wait. You Act.This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredBREAKING: Trump vs. Elon Feud Threatens Your Retirement – Protect Yourself NOW"This isn't just a war of words. This is a financial time bomb. The escalating battle between Donald Trump a...American Alternative | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredThe one deadline Elon can't afford to miss...For years, Elon Musk made headlines for blowing past deadlines — so often that investors coined a nickname for...Brownstone Research | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding PureTech Health plc Please log in to your account or sign up in order to add this asset to your watchlist. Share PureTech Health With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.